Dr. Wolfram Lux is a Senior Director in the global Pharma & Biotech practice within Simon-Kucher & Partners Life Sciences Division, working beginning of 2019 out of the company’s office in Munich, Germany. Previously, he acted as General Manager of a Life Sciences Consultancy in Dusseldorf for 3 years and before that he was a senior principal in IQVIA’s (formerly IMS Consulting Group) Launch and Commercial Strategy division for 6 years. Mr. Lux held industry positions as Medical Liaison, Marketer and as Business Unit head in the onco-pharmaceutical industry too.
He received his diploma degree in Chemistry from ETH Zürich and a bachelor in business administration from the University of Hagen, Germany in 1996, respectively 1999. He received his PhD in 2001 from the Free University of Berlin in Molecular Biology with a focus on gene expression control in brain cancer and in cooperation with his pharmaceutical company sponsor Schering AG, Berlin (PhD grant).
Dr. Wolfram Lux specializes in strategic pharmaceutical commercialization, launch- and brand excellence, portfolio- and lifecycle-management, including go-to-market strategies, P&MA strategies, product lifecycle strategies and orphan diseases. He has supported many of the current top-25 pharma and medtech companies in successfully planning and commercializing their healthcare innovations in Europe and the USA. He has published various articles on pharmaceutical launch, marketing and payer strategy in industry executive journals.